GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BPTH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Bio-Path Holdings stock price on Thursday which ended trading at $4.20
(Updated on Apr 18, 2024)

Hold candidate since Apr 18, 2024 PDF

The Bio-Path Holdings stock price gained 29.63% on the last trading day (Thursday, 18th Apr 2024), rising from $3.24 to $4.20. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 115.45% from a day low at $3.56 to a day high of $7.67. The price has fallen in 7 of the last 10 days and is down by -2.33% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 82 million more shares were traded than the day before. In total, 83 million shares were bought and sold for approximately $348.24 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.17 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 117.30% during the next 3 months and, with a 90% probability hold a price between $6.88 and $18.94 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BPTH Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bio-Path Holdings stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.58. On a fall, the stock will find some support from the short-term average at $3.30. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -34.78%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Bio-Path Holdings stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.78 and $3.46. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Bio-Path Holdings finds support just below today's level at $3.78. If this is broken, then the next support from accumulated volume will be at $3.46 and $3.24.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $4.11 between high and low, or 115.45%. For the last week, the stock has had daily average volatility of 34.42%.

Our recommended stop-loss: $3.95 (-5.98%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 30 days ago.)

Trading Expectations (BPTH) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Bio-Path Holdings to open at $5.14, and during the day (based on 14 day Average True Range), to move between $3.40 and $5.00, which gives a possible trading interval of +/-$0.795 (+/-18.93%) up or down from last closing price. If Bio-Path Holdings takes out the full calculated possible swing range there will be an estimated 37.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.35 (3.57%) than the support at $3.78 (10.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bio-Path Holdings stock A Buy?

Bio-Path Holdings holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.312 Hold/Accumulate Upgraded

Predicted Opening Price for Bio-Path Holdings of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$5.14 ( 22.46%) $4.20

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BPTH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.25 120.31 %
R2 7.68 82.93 %
R1 6.71 59.84 %
Current price: 4.20
Support S1 3.57 -14.92 %
S2 2.60 -38.01 %
S3 1.03 -75.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.86 15.71 %
R2 4.60 9.52 %
R1 4.35 3.57 %
Current price 4.20
Support S1 3.78 -10.00%
S2 3.46 -17.62%
S3 3.24 -22.86%

FAQ

What is the symbol for Bio-Path Holdings Stock and on which exchange is it traded?
The symbol for Bio-Path Holdings is BPTH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bio-Path Holdings Stock?
Bio-Path Holdings holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Bio-Path Holdings Stock?
Bio-Path Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bio-Path Holdings Stock.

What's the current price of Bio-Path Holdings Stock?
As of the end of day on the 2024-04-18, the price of an Bio-Path Holdings (BPTH) share was $4.20.

What is the 52-week high and low for Bio-Path Holdings Stock?
The 52-week high for Bio-Path Holdings Stock is $7.67 and the 52-week low is $0.320.

What is the market capitalization of Bio-Path Holdings Stock?
As of the 2024-04-18, the market capitalization of Bio-Path Holdings is 3.166M.

When is the next earnings date for Bio-Path Holdings?
The upcoming earnings date for Bio-Path Holdings is May 10, 2024.
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT